Showing results (731-740 of 2,002) with videos related to
Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|October 7, 2017
Ankylosing Spondylitis Among Familial Mediterranean Fever PatientsMira Merashli, Mohammad Hassan A Noureldine, Yehia Tfayli, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|October 1, 2015
Hypopituitarism in Neurocritical Patients: A Case ReportMichele Iovino, Nicola Iovine, Fiorentino Mondillo, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 8, 2017
Current and Under Development Treatment Modalities of Psoriasis: A ReviewAbdullah AlbaghdadiEndocrine, Metabolic & Immune Disorders Drug Targets|November 19, 2017
Olive Oil-related Anti-inflammatory Effects on Atherosclerosis: Potential Clinical ImplicationsTanakal Wongwarawipat, Nikolaos Papageorgiou, Dimitrios Bertsias, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|November 28, 2017
Quality of Life in Individuals Affected by Arnold Chiari Malformation: Comparison and Validation of a Measurement InstrumentAntonio Martinez-Sabater, Maria Luisa Ballestar-Tarin, Miriam Vazquez-Seoane, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|November 23, 2017
Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable AntipsychoticsVanessa Sanchez-Martinez, Dolores Romero-Rubio, Maria Jose Abad-Perez, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|November 23, 2017
Effects of Olive Oil on TNF-α and IL-6 in Humans: Implication in Obesity and FrailtyNagendra S Yarla, Angela Polito, Ilaria PelusoEndocrine, Metabolic & Immune Disorders Drug Targets|December 13, 2017
Neuroendocrine and Metabolic Disorders in Bulimia NervosaWalter Milano, Anna CapassoEndocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine NeoplasmsFranco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
Crigler-Najjar Syndrome: Current Perspectives and the Application of Clinical GeneticsAmmar Ebrahimi, Fakher RahimPageof 201